However, no obvious change was observed in the percentage of Treg cells in each group (Fig. 6c), indicating that the anti-tumor mechanism of anti-PD-1 antibody and cisplatin were independent of Treg cell consumption. This evidence concerns the gene PDCD1 and neoplasm.